-
公开(公告)号:US20220372131A1
公开(公告)日:2022-11-24
申请号:US17882932
申请日:2022-08-08
Applicant: Genentech, Inc.
Inventor: ChinYu Lin , Theodore A. Omachi , Ryan P. Owen , Karl Yen , Yanan Zheng , Kendra Debusk
IPC: C07K16/24 , A61P17/00 , A61K9/00 , A61K9/19 , A61K31/573 , A61K39/395
Abstract: Uses of IL-13 antagonists for treating atopic dermatitis are provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering IL-13 antagonists.
-
公开(公告)号:US11226341B2
公开(公告)日:2022-01-18
申请号:US15992115
申请日:2018-05-29
Applicant: GENENTECH, INC.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: A61K39/395 , G01N33/68 , C07K16/28 , C07K16/24 , C07K16/18 , A61K31/522 , A61K31/573 , A61K45/06
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
-
公开(公告)号:US09684000B2
公开(公告)日:2017-06-20
申请号:US14021698
申请日:2013-09-09
Applicant: Genentech, Inc.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: C07K16/00 , G01N33/68 , C07K16/28 , A61K39/395 , C07K16/18 , A61K31/522 , A61K31/573 , A61K45/06
CPC classification number: G01N33/6884 , A61K31/522 , A61K31/573 , A61K39/3955 , A61K39/39566 , A61K45/06 , C07K16/18 , C07K16/28 , G01N33/6887 , G01N33/6893 , G01N2333/475 , G01N2800/122 , G01N2800/52
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
-
公开(公告)号:US20140044645A1
公开(公告)日:2014-02-13
申请号:US14021698
申请日:2013-09-09
Applicant: Genentech, Inc.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: G01N33/68 , A61K39/395 , C07K16/18
CPC classification number: G01N33/6884 , A61K31/522 , A61K31/573 , A61K39/3955 , A61K39/39566 , A61K45/06 , C07K16/18 , C07K16/28 , G01N33/6887 , G01N33/6893 , G01N2333/475 , G01N2800/122 , G01N2800/52
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
-
公开(公告)号:US11434286B2
公开(公告)日:2022-09-06
申请号:US16356309
申请日:2019-03-18
Applicant: Genentech, Inc.
Inventor: ChinYu Lin , Theodore A. Omachi , Ryan P. Owen , Karl Yen , Yanan Zheng , Kendra Debusk
IPC: A61K39/395 , C07K16/24 , A61P17/00 , A61K9/00 , A61K9/19 , A61K31/573 , A61K39/00
Abstract: Uses of IL-13 antagonists for treating atopic dermatitis are provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering IL-13 antagonists.
-
公开(公告)号:US20190270803A1
公开(公告)日:2019-09-05
申请号:US16356309
申请日:2019-03-18
Applicant: Genentech, Inc.
Inventor: ChinYu Lin , Theodore A. Omachi , Ryan P. Owen , Karl Yen , Yanan Zheng , Kendra Debusk
IPC: C07K16/24 , A61K31/573 , A61K9/00 , A61K9/19 , A61P17/00
Abstract: Uses of IL-13 antagonists for treating atopic dermatitis are provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering IL-13 antagonists.
-
公开(公告)号:US09995755B2
公开(公告)日:2018-06-12
申请号:US14021947
申请日:2013-09-09
Applicant: Genentech, Inc.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: A61K39/00 , A61K45/00 , G01N33/68 , C07K16/28 , A61K39/395 , C07K16/18 , A61K31/522 , A61K31/573 , A61K45/06
CPC classification number: G01N33/6884 , A61K31/522 , A61K31/573 , A61K39/3955 , A61K39/39566 , A61K45/06 , C07K16/18 , C07K16/28 , G01N33/6887 , G01N33/6893 , G01N2333/475 , G01N2800/122 , G01N2800/52
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
-
公开(公告)号:US20190120854A1
公开(公告)日:2019-04-25
申请号:US15992115
申请日:2018-05-29
Applicant: GENENTECH, INC.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: G01N33/68 , C07K16/24 , A61K31/573 , A61K31/522 , A61K45/06 , A61K39/395 , C07K16/28 , C07K16/18
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
-
公开(公告)号:US20140044702A1
公开(公告)日:2014-02-13
申请号:US14021947
申请日:2013-09-09
Applicant: Genentech, Inc.
Inventor: Joseph R. Arron , Richard W. Erickson , Michelle Freemer , Meredith Hazen , Guiquan Jia , John G. Matthews , Wendy Putnam , Heleen Scheerens , Yanan Zheng
IPC: G01N33/68 , A61K31/522 , A61K45/06 , A61K39/395 , A61K31/573
CPC classification number: G01N33/6884 , A61K31/522 , A61K31/573 , A61K39/3955 , A61K39/39566 , A61K45/06 , C07K16/18 , C07K16/28 , G01N33/6887 , G01N33/6893 , G01N2333/475 , G01N2800/122 , G01N2800/52
Abstract: Methods of diagnosing and treating disorders related to TH2 inhibition, including but not limited to asthma, are provided. Also provided are methods of selecting or identifying patients for treatment with certain therapeutic agents that are TH2 pathway inhibitors.
Abstract translation: 提供了诊断和治疗与TH2抑制有关的疾病的方法,包括但不限于哮喘。 还提供了选择或鉴定患者以治疗TH2途径抑制剂的某些治疗剂的方法。
-
-
-
-
-
-
-
-